首页 产品目录 全部产品 (8R,9S,13S,14S,17S)-17-methoxy-13-methyl-3-propoxy-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene

(8R,9S,13S,14S,17S)-17-methoxy-13-methyl-3-propoxy-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene

(8R,9S,13S,14S,17S)-17-methoxy-13-methyl-3-propoxy-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

39219-28-8

英文名称

(8R,9S,13S,14S,17S)-17-methoxy-13-methyl-3-propoxy-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene

别名

17β-Methoxy-3-propoxyestra-1,3,5(10)-triene;17()-17-Methoxy-3-propoxy-estra-1,3,5(10)-triene;3-Propoxy-17-methoxyestra-1,3,5(10)-triene;3-Propoxy-17-methoxyoestra-1,3,5(10)-triene;3-Propoxy-17b-methoxyestra-1,3,5(10)-trien;17(b)-17-Methoxy-3-propoxy-estra-1,3,5(10)-triene;PROMESTRIENE;17-BETA-ESTRADIOL 3-PROPYL ETHER 17-METHYL ETHER

标准英文名

(8R,9S,13S,14S,17S)-17-methoxy-13-methyl-3-propoxy-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene

分子式

C22H32O2

分子量

328.50

精确分子量

328.24

SMILES

CCCOC1=CC=C2C(=C1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC)CC[C@@H]12

标准SMILES

CO[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=CC=C4[C@H]3CC[C@@]21C)OCCC

用途

Promestriene is a topical estrogenic agent used for the prevention and treatment of atrophic vaginitis and other estrogen deficiency-related conditions in the vulvovaginal area. It is indicated for: 1. Topical cream or ointment: Treatment of atrophic lesions of the vulva, vestibule, and vaginal introitus. 2. Vaginal capsules: Management of vaginal atrophy due to estrogen deficiency; promotion of healing in mucosal injuries of the cervix, vagina, and vulva caused by childbirth, local surgery, or physical therapies (e.g., laser, cryotherapy, or cauterization). It exerts strictly local estrogenic effects by thickening the vaginal epithelium, restoring vaginal pH balance, improving the vaginal microenvironment, and enhancing local resistance to infection, without systemic estrogenic activity. Due to its minimal systemic absorption, it avoids the systemic risks associated with long-term local estrogen therapy and is particularly suitable for patients with estrogen-dependent diseases. Promestriene is also used in combination therapies: - Combined with recombinant human interferon α-2b vaginal effervescent capsules for atrophic vaginitis (total effective rate: 96%). - Combined with live Lactobacillus preparations for atrophic vaginitis (cure rate: 95%). - Combined with metronidazole for bacterial vaginosis (total effective rate: 92.50%, low recurrence, no adverse reactions reported).

InChIKey

IUWKNLFTJBHTSD-AANPDWTMSA-N

安全信息

SureRoute逆合成路线

1.  39219-28-8 逆合成路线 1

—
—
—
—
ACKTJX986
39219-28-8
来源: SureRoute

2.  39219-28-8 逆合成路线 2

—
—
—
—
ACKTJX986
39219-28-8
来源: SureRoute

3.  39219-28-8 逆合成路线 3

—
—
—
—
ACKTJX986
39219-28-8
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手